Wall Street Experts
ver. ZuMIgo(08/25)
Chengdu Kanghua Biological Products Co., Ltd.
Rachunek Zysków i Strat
Przychody TTM (mln): 1 639
EBIT TTM (mln): 665
| index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
| Rok finansowy |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
| Przychód (mln) |
71 |
93 |
262 |
559 |
555 |
1,039 |
1,292 |
1,447 |
1,568 |
1,432 |
| Przychód Δ r/r |
0.0% |
30.7% |
181.9% |
113.6% |
-0.9% |
87.3% |
24.4% |
11.9% |
8.4% |
-8.7% |
| Marża brutto |
84.4% |
90.7% |
89.5% |
94.4% |
94.2% |
93.9% |
93.5% |
93.6% |
90.9% |
94.2% |
| EBIT (mln) |
13 |
7 |
91 |
190 |
223 |
485 |
916 |
686 |
599 |
467 |
| EBIT Δ r/r |
0.0% |
-50.1% |
1249.9% |
108.6% |
17.8% |
117.1% |
88.8% |
-25.1% |
-12.6% |
-22.0% |
| EBIT (%) |
19.0% |
7.2% |
34.7% |
33.9% |
40.3% |
46.7% |
70.9% |
47.4% |
38.2% |
32.6% |
| Koszty finansowe (mln) |
12 |
10 |
5 |
0 |
1 |
0 |
0 |
3 |
5 |
5 |
| EBITDA (mln) |
40 |
38 |
113 |
224 |
240 |
502 |
953 |
767 |
661 |
538 |
| EBITDA(%) |
55.7% |
41.4% |
43.0% |
40.0% |
43.3% |
48.3% |
73.7% |
53.0% |
42.2% |
37.5% |
| Podatek (mln) |
3 |
0 |
16 |
35 |
37 |
76 |
86 |
86 |
65 |
68 |
| Zysk Netto (mln) |
12 |
7 |
74 |
154 |
187 |
408 |
829 |
598 |
509 |
399 |
| Zysk netto Δ r/r |
0.0% |
-43.1% |
1018.3% |
107.0% |
21.1% |
118.6% |
103.3% |
-27.9% |
-14.9% |
-21.7% |
| Zysk netto (%) |
16.5% |
7.2% |
28.4% |
27.6% |
33.7% |
39.3% |
64.2% |
41.3% |
32.5% |
27.8% |
| EPS |
0.0 |
0.0 |
0.0 |
1.54 |
1.38 |
3.02 |
6.15 |
4.47 |
3.78 |
3.03 |
| EPS (rozwodnione) |
0.0 |
0.0 |
0.0 |
1.54 |
1.38 |
3.02 |
6.14 |
4.46 |
3.78 |
3.03 |
| Ilośc akcji (mln) |
0 |
0 |
0 |
100 |
135 |
135 |
135 |
134 |
135 |
132 |
| Ważona ilośc akcji (mln) |
0 |
0 |
0 |
100 |
135 |
135 |
135 |
134 |
135 |
132 |
| Waluta |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |